Attention-Deficit/Hyperactivity Disorder (ADHD)
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: web-based questionnaire Survey -Those who were willing to participate in the survey, understood the contents of the informed consent form for the survey, and gave consent to participation in the survey -Male or female patients >= 18 to < 65 years of age at the time of informed consent. -The subject are living in Japan at the time of the questionnaire. Inclusion criteria for each study population are as follows: -Adult ADHD patients: individuals who have diagnosis of ADHD -Adult families of adult ADHD patients: individuals who do not have diagnosis of ADHD, family members living together are diagnosed with ADHD and aged 18 years or older. -ASRS-positive non-ADHD adults: individuals who do not have diagnosis of ADHD, family members living together have not been diagnosed with ADHD, and ASRS*-positive(>= 4)** -ASRS-negative non-ADHD adults: individuals who do not have diagnosis of ADHD, family members living together have not been diagnosed with ADHD, and ASRS negative(< 4) **At least 4 out of 6 questions about symptom frequency in Part A of the Japanese version of the Adult ADHD Self-Report Scale (ASRS, v1.1) are above the prespecifi edcriteria. Database analysis -Patients diagnosed with 'other mental and behavioral disorders' (including ADHD), and having a health insurance claim in the JMDC database -Patients registered in the JMDC database for the year to be analysed -For ADHD, the patients aged >= 18 and < 65 years in the year to be analysed
Exclusion criteria
Exclusion criteria: A web-based questionnaire Survey -Not applicable Database analysis -Not applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Socioeconomic Burden of Adult ADHD The costs of medical care, social security services, and productivity loss (the cost of lost employment, reduced salary and reduced work productivity defined by absenteeism and presenteeism) in adult ADHD patients and productivity loss in adult families of adult ADHD patients and their aggregate values are estimated. | — |
Countries
Japan
Contacts
Takeda Pharmaceutical Company Limited. Japan Medical Office